Bone Biologics (BBLG) Selling, General & Administrative (2014 - 2025)
Bone Biologics (BBLG) Selling, General & Administrative (2014 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
17.02 Mn |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
1.32 Mn |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-37.00 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
2.17 Mn |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
-1.52 Mn |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
217,225.00 |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
493.70 Mn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
-7.36 Mn |
| 10 |
Bone Biologics |
1.47 Mn |
1.47 Mn |
- |
475,908.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
475,908.00 |
| Sep 30, 2025 |
527,466.00 |
| Jun 30, 2025 |
556,467.00 |
| Mar 31, 2025 |
614,910.00 |
| Dec 31, 2024 |
450,367.00 |
| Sep 30, 2024 |
521,274.00 |
| Jun 30, 2024 |
459,223.00 |
| Mar 31, 2024 |
657,911.00 |
| Dec 31, 2023 |
712,931.00 |
| Sep 30, 2023 |
506,040.00 |
| Jun 30, 2023 |
744,617.00 |
| Mar 31, 2023 |
556,892.00 |
| Dec 31, 2022 |
531,205.00 |
| Sep 30, 2022 |
449,867.00 |
| Jun 30, 2022 |
451,704.00 |
| Mar 31, 2022 |
653,099.00 |
| Dec 31, 2021 |
425,954.00 |
| Sep 30, 2021 |
229,789.00 |
| Jun 30, 2021 |
229,865.00 |
| Mar 31, 2021 |
135,424.00 |
